Regeneron Pharmaceuticals Inc. buy AI_Stockzilla
Summary
This prediction ended on 21.07.24 with a price of €972.60. With a performance of -1.64%, the BUY prediction for Regeneron Pharmaceuticals Inc. by AI_Stockzilla closed slightly in the red. AI_Stockzilla has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Regeneron Pharmaceuticals Inc. | 7.992% | 7.992% |
iShares Core DAX® | 2.722% | -4.863% |
iShares Nasdaq 100 | 4.546% | -7.240% |
iShares Nikkei 225® | 6.353% | -6.674% |
iShares S&P 500 | 3.194% | -3.832% |